Volume 12, Number 6—June 2006
Dispatch
West Nile Virus Infection in Humans and Horses, Cuba
Maritza Pupo*
, Maria Guadalupe Guzmán*, Roberto Fernández*, Alina Llop*, Félix Orlando Dickinson*, Daniel Pérez*, Raúl Cruz†, Tayri González†, Gonzalo Estévez†, Hiram González‡, Paulino Santos§, Gustavo Kourí*, Maya Andonova¶, Robbin Lindsay¶, Harvey Artsob¶, and Michael Drebot¶
, Maria Guadalupe Guzmán*, Roberto Fernández*, Alina Llop*, Félix Orlando Dickinson*, Daniel Pérez*, Raúl Cruz†, Tayri González†, Gonzalo Estévez†, Hiram González‡, Paulino Santos§, Gustavo Kourí*, Maya Andonova¶, Robbin Lindsay¶, Harvey Artsob¶, and Michael Drebot¶
Table 1
Summary of horse sera tested for evidence of WNV infection by ELISA and PRNT*
| Sample no. | % inhibition (ELISA) |
90% PRNT titer |
|||
|---|---|---|---|---|---|
| Anti-WNV | Antiflavivirus | WNV | SLEV | Interpretation | |
| C-7 | 65.3 | 65.2 | 160 | 20 | WNV |
| C-13 | 58.9 | 60.4 | 320 | – | WNV |
| C-19 | 63.2 | 63.3 | 320 | – | WNV |
| C-20 | 74.6 | 62.2 | 640 | – | WNV |
| C-2 | 44.4 | 60.4 | – | 20 | SLEV |
| C-4 | 11.6 | 40.1 | – | 20 | SLEV |
| C-5 | 67.5 | 67.6 | – | 20 | SLEV |
| C-11 | 10.5 | 26.7 | – | 40 | SLEV |
| C-12 | 32.2 | 68.0 | – | 20 | SLEV |
| C-15 | 27.4 | 68.9 | – | 40 | SLEV |
| C-16 | 64.6 | 65.7 | – | 40 | SLEV |
| C-18 | 59.1 | 68.2 | – | 40 | SLEV |
| C-10 | 62.7 | 66.3 | 80 | 40 | Unidentified flavivirus |
| C-1 | 22.3 | 74.4 | – | – | Unidentified flavivirus |
| C-3 | 40.5 | 54.1 | – | – | Unidentified flavivirus |
| C-6 | 28.5 | 74.8 | – | – | Unidentified flavivirus |
| C-9 | 40.9 | 73.6 | – | – | Unidentified flavivirus |
| C-14 | 34.8 | 41.0 | – | – | Unidentified flavivirus |
| C-21 | 9.9 | 68.4 | – | – | Unidentified flavivirus |
*WNV, West Nile virus; ELISA, enzyme-linked immunosorbent assay; PRNT, plaque reduction neutralization test; SLEV, Saint Louis encephalitis virus.
Page created: January 04, 2012
Page updated: January 04, 2012
Page reviewed: January 04, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.